tiprankstipranks
Advertisement
Advertisement

IPHYF Stock Latest News

Innate Pharma to Showcase Oncology Pipeline at AACR 2026 Partnering Event
Company AnnouncementsInnate Pharma to Showcase Oncology Pipeline at AACR 2026 Partnering Event
4d ago
6K
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
PremiumRatings
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
5d ago
IPHA
Innate Pharma Balances Pipeline Progress With Cash Strain
PremiumCompany Announcements
Innate Pharma Balances Pipeline Progress With Cash Strain
9d ago
Innate Pharma to Engage Investors at Kempen Life Sciences Conference in Amsterdam
PremiumCompany Announcements
Innate Pharma to Engage Investors at Kempen Life Sciences Conference in Amsterdam
9d ago
6K
Innate Pharma Files 2025 Annual Reports with AMF and U.S. SEC
PremiumCompany Announcements
Innate Pharma Files 2025 Annual Reports with AMF and U.S. SEC
10d ago
6K
Innate Pharma Posts 2025 Results, Flags H2 2026 CTCL Phase 3 Start Amid Cash Runway to Q3
PremiumCompany AnnouncementsInnate Pharma Posts 2025 Results, Flags H2 2026 CTCL Phase 3 Start Amid Cash Runway to Q3
17d ago
6K
Innate Pharma Sets March 26 Webcast to Present Full-Year 2025 Results
Premium
Company Announcements
Innate Pharma Sets March 26 Webcast to Present Full-Year 2025 Results
24d ago
6K
Innate Pharma assumed with a Buy at BTIG
Premium
The Fly
Innate Pharma assumed with a Buy at BTIG
1M ago
IPHA
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
PremiumRatings
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
1M ago
IPHA
Innate Pharma to Spotlight Cancer Immunotherapy Pipeline at Leerink Global Healthcare Conference
PremiumCompany Announcements
Innate Pharma to Spotlight Cancer Immunotherapy Pipeline at Leerink Global Healthcare Conference
2M ago
6K
Innate Pharma Updates Share Capital and Voting Rights as of December 31, 2025
PremiumCompany Announcements
Innate Pharma Updates Share Capital and Voting Rights as of December 31, 2025
3M ago
6K
Innate Pharma Updates Share Capital and Voting Rights as of December 18, 2025
PremiumCompany Announcements
Innate Pharma Updates Share Capital and Voting Rights as of December 18, 2025
4M ago
6K
Innate Pharma Announces 2026 Financial Calendar
PremiumCompany AnnouncementsInnate Pharma Announces 2026 Financial Calendar
4M ago
6K
Innate Pharma Releases Share and Voting Rights Update as of November 27, 2025
Premium
Company Announcements
Innate Pharma Releases Share and Voting Rights Update as of November 27, 2025
5M ago
6K
Innate Pharma Presents at Jefferies Global Healthcare Conference 2025
Premium
Company Announcements
Innate Pharma Presents at Jefferies Global Healthcare Conference 2025
5M ago
6K
Innate Pharma’s Q3 2025 Update: FDA Clears Phase 3 Trial for Lacutamab
PremiumCompany Announcements
Innate Pharma’s Q3 2025 Update: FDA Clears Phase 3 Trial for Lacutamab
5M ago
6K
Innate Pharma Receives FDA Clearance for Phase 3 Lacutamab Trial
PremiumCompany Announcements
Innate Pharma Receives FDA Clearance for Phase 3 Lacutamab Trial
5M ago
6K
Innate Pharma announces FDA clearance to proceed with TELLOMAK 3 trial
PremiumThe Fly
Innate Pharma announces FDA clearance to proceed with TELLOMAK 3 trial
5M ago
IPHA
Innate Pharma Schedules Q3 2025 Results Conference Call
PremiumCompany Announcements
Innate Pharma Schedules Q3 2025 Results Conference Call
5M ago
6K
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyInnate Pharma upgraded to Buy from Neutral at H.C. Wainwright
6M ago
IPHA
Innate Pharma’s IPH4502: A Promising Step in Cancer Treatment
Premium
Company Announcements
Innate Pharma’s IPH4502: A Promising Step in Cancer Treatment
6M ago
IPHYF
Innate Pharma’s Promising NSCLC Study: A Potential Game-Changer?
Premium
Company Announcements
Innate Pharma’s Promising NSCLC Study: A Potential Game-Changer?
6M ago
IPHYF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >